Part 2 Of 2 Comment/Reply on ACT/Ocata Lancet Report (Oct. 2014)
Reply by, *Steven D Schwartz, Eddy Anglade, Robert Lanza, on behalf of the Ocata
Macular Disease Investigator Group
schwartz@jsei.ucla.edu
Jules Stein Eye Institute Retina Division, and David
Geffen School of Medicine, University of California,
Los Angeles, CA 90095, USA (SDS); and Ocata
Therapeutics Inc, Marlborough, MA, USA (EA, RL)
Source Material: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(15)61203-X.pdf
This document summarizes Shahram Eivazi's doctoral dissertation on eye gaze patterns in micro-neurosurgery. The dissertation explores whether the eye movement patterns of novice and expert neurosurgeons differ when observing tumor removal recordings. It describes the development of the world's first surgical microscope with an embedded eye tracker to study gazes in neurosurgery. The dissertation finds that expert microsurgeons have an extra ability to long fixate on micro-anatomies and maintain attention on task-relevant areas, demonstrating an information-reduction strategy of visual expertise.
The Lancet - Human embryonic stem cell-derived retinal pigment epithelium in...John Redaelli
This summarizes the results of two clinical trials evaluating the safety and efficacy of transplanting human embryonic stem cell-derived retinal pigment epithelium (hESC-RPE) in patients with Stargardt's macular dystrophy or dry age-related macular degeneration. A total of 18 patients received subretinal injections of hESC-RPE in one eye. Over a median follow-up of 22 months, there were no safety issues identified and 72% of patients showed signs of graft survival. Visual acuity improved in some patients and quality of life measures increased, suggesting possible biological activity. The results provide initial evidence that hESC-derived cells can be safely transplanted and have potential for treating retinal diseases
Cortical spreading depolarizations are waves of neuronal and astrocyte depolarization that propagate through brain tissue and are associated with worse clinical outcomes after traumatic brain injury. The study found that over 50% of patients with brain injury experienced spreading depolarizations when monitored with electrocorticography. In a multivariate analysis controlling for established prognostic factors, spreading depolarizations remained independently associated with unfavorable six-month outcomes. The results suggest spreading depolarizations are a pathomechanism with adverse effects on the injured brain that could potentially be targeted by new therapies.
Trevor Pickersgill, looking to the future, treatmentsMS Trust
This document discusses potential directions for multiple sclerosis (MS) research and treatment over the next 21 years. It outlines a desire for more effective anti-inflammatory drugs, restorative therapies, and potentially a cure. It also advocates for organized inpatient care units for MS patients, increased prevention efforts through identifying risk factors, and more trials in progressive MS. The document discloses several potential conflicts of interest for the author in relation to MS drug companies.
OCT technology allows for fast, objective, and demonstrative screening and diagnosis of eye conditions like AMD, glaucoma, ERM, and diabetes in under 6 minutes per patient without pupil dilation. It scans the macula and optic disc and has advantages like increasing accurate diagnosis and patient confidence while reducing office visit times compared to traditional screening methods.
Corneal opacities in infants and children pose unique
management challenges. Penetrating Keratoplasty (PKP) has been used in order to clear the visual axis and prevent amblyopia, but has been historically associated with high rates of graft failure and other complications
Brain monitoring using intraparenchymal cathterspgpapanikolaou
This document summarizes the experience of using intraparenchymal brain catheters for multimodal neuromonitoring in 54 patients with traumatic brain injury or subarachnoid hemorrhage. The catheters were inserted using a single burr hole in the skull to monitor intracranial pressure, brain tissue oxygen, and microdialysis. The procedure was performed safely at the bedside in the ICU with a low complication rate and no clinically significant infections. Monitoring data from intracranial pressure, brain tissue oxygen, and microdialysis biochemistry helped guide treatment to maintain a cerebral perfusion pressure over 60 mmHg and intracranial pressure below 20 mmHg. Multimodal neuromon
Part 2 Of 2 Comment/Reply on ACT/Ocata Lancet Report (Oct. 2014)
Reply by, *Steven D Schwartz, Eddy Anglade, Robert Lanza, on behalf of the Ocata
Macular Disease Investigator Group
schwartz@jsei.ucla.edu
Jules Stein Eye Institute Retina Division, and David
Geffen School of Medicine, University of California,
Los Angeles, CA 90095, USA (SDS); and Ocata
Therapeutics Inc, Marlborough, MA, USA (EA, RL)
Source Material: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(15)61203-X.pdf
This document summarizes Shahram Eivazi's doctoral dissertation on eye gaze patterns in micro-neurosurgery. The dissertation explores whether the eye movement patterns of novice and expert neurosurgeons differ when observing tumor removal recordings. It describes the development of the world's first surgical microscope with an embedded eye tracker to study gazes in neurosurgery. The dissertation finds that expert microsurgeons have an extra ability to long fixate on micro-anatomies and maintain attention on task-relevant areas, demonstrating an information-reduction strategy of visual expertise.
The Lancet - Human embryonic stem cell-derived retinal pigment epithelium in...John Redaelli
This summarizes the results of two clinical trials evaluating the safety and efficacy of transplanting human embryonic stem cell-derived retinal pigment epithelium (hESC-RPE) in patients with Stargardt's macular dystrophy or dry age-related macular degeneration. A total of 18 patients received subretinal injections of hESC-RPE in one eye. Over a median follow-up of 22 months, there were no safety issues identified and 72% of patients showed signs of graft survival. Visual acuity improved in some patients and quality of life measures increased, suggesting possible biological activity. The results provide initial evidence that hESC-derived cells can be safely transplanted and have potential for treating retinal diseases
Cortical spreading depolarizations are waves of neuronal and astrocyte depolarization that propagate through brain tissue and are associated with worse clinical outcomes after traumatic brain injury. The study found that over 50% of patients with brain injury experienced spreading depolarizations when monitored with electrocorticography. In a multivariate analysis controlling for established prognostic factors, spreading depolarizations remained independently associated with unfavorable six-month outcomes. The results suggest spreading depolarizations are a pathomechanism with adverse effects on the injured brain that could potentially be targeted by new therapies.
Trevor Pickersgill, looking to the future, treatmentsMS Trust
This document discusses potential directions for multiple sclerosis (MS) research and treatment over the next 21 years. It outlines a desire for more effective anti-inflammatory drugs, restorative therapies, and potentially a cure. It also advocates for organized inpatient care units for MS patients, increased prevention efforts through identifying risk factors, and more trials in progressive MS. The document discloses several potential conflicts of interest for the author in relation to MS drug companies.
OCT technology allows for fast, objective, and demonstrative screening and diagnosis of eye conditions like AMD, glaucoma, ERM, and diabetes in under 6 minutes per patient without pupil dilation. It scans the macula and optic disc and has advantages like increasing accurate diagnosis and patient confidence while reducing office visit times compared to traditional screening methods.
Corneal opacities in infants and children pose unique
management challenges. Penetrating Keratoplasty (PKP) has been used in order to clear the visual axis and prevent amblyopia, but has been historically associated with high rates of graft failure and other complications
Brain monitoring using intraparenchymal cathterspgpapanikolaou
This document summarizes the experience of using intraparenchymal brain catheters for multimodal neuromonitoring in 54 patients with traumatic brain injury or subarachnoid hemorrhage. The catheters were inserted using a single burr hole in the skull to monitor intracranial pressure, brain tissue oxygen, and microdialysis. The procedure was performed safely at the bedside in the ICU with a low complication rate and no clinically significant infections. Monitoring data from intracranial pressure, brain tissue oxygen, and microdialysis biochemistry helped guide treatment to maintain a cerebral perfusion pressure over 60 mmHg and intracranial pressure below 20 mmHg. Multimodal neuromon
1. Brain atrophy occurs across all stages of multiple sclerosis (MS), with around 40% of cortical neurons being lost over a lifetime without intervention. Early treatment with disease-modifying therapies (DMT) can help reduce disability and protect brain health.
2. Both inflammatory lesions and neurodegeneration are associated with disability progression in MS. Gadolinium-enhancing lesions are not fully indicative of disease phenotypes and inflammation may be present even without new lesions.
3. DMT have been shown to reduce disability accrual even at advanced stages of MS. While early treatment is important, evidence suggests that people with progressive forms may also benefit. Interventions should focus on outcomes beyond just lesion activity.
This document discusses the impact of meningitis on the brain and an overview of neurorehabilitation for children with neurological sequelae from meningitis. It provides details on the pathophysiology of meningitis and how it can cause brain damage. The document also presents clinical evidence from cases of meningitis, including outcomes and the incidence of post-meningitic hydrocephalus requiring shunt surgery. It concludes with an overview of neurorehabilitation services and a proposed model for a regional pediatric neurorehabilitation network.
This document discusses the formation and roles of support groups for transmissible spongiform encephalopathies (TSEs) like Creutzfeldt-Jakob disease (CJD) over time. It outlines the timeline of when major support groups around the world were established from 1992 to present. It also discusses the challenges faced in understanding and finding treatments for these fatal neurodegenerative diseases.
This document provides an overview of multiple sclerosis (MS) models and the challenges of translating findings from animal models to clinical applications. It discusses key aspects of MS like pathogenesis, clinical courses, and neurodegeneration. Common MS models like experimental autoimmune encephalomyelitis (EAE) are described along with their limitations in mimicking the human disease. Issues like preclinical failure to translate findings and limitations of experimental design that can contribute to clinical trial failures are reviewed. Guidelines for improving experimental design and reporting are also mentioned.
This document discusses recent developments in the treatment of multiple sclerosis (MS). It notes that early treatment with immunomodulatory therapies can slow disease progression and reduce future disability. Patients presenting with a clinically isolated syndrome or radiologically isolated syndrome, who have abnormal MRI findings but no or limited symptoms, are now treated early to prevent or delay their first clinical relapse of MS. The document reviews the inflammatory and demyelinating nature of MS and how the newly discovered glymphatic system may help immune cells enter the central nervous system to cause MS lesions.
Neurological Aspects of Tuberous Sclerosis Ade Wijaya
Tuberous sclerosis is an autosomal dominant genetic disorder that affects multiple organ systems. More than 90% of individuals experience neurological effects including epilepsy and neuropsychiatric symptoms. Brain imaging reveals tubers, subependymal nodules, and other abnormalities. Treatment involves early and aggressive treatment of epilepsy as well as mTOR inhibitors which target the molecular basis of the condition.
This document summarizes primary nervous system tumors in adults. It discusses that primary brain tumors arise from different central nervous system cells and account for about 2% of cancers. Meningiomas are the most common non-malignant tumors, while gliomas account for 75% of malignant brain tumors, over half being glioblastomas. Symptoms, diagnostic imaging techniques, treatment options including surgery, radiation therapy, chemotherapy are described. The management of primary brain tumors in adults and children of different age groups is summarized.
This document discusses progressive multiple sclerosis (MS) and whether it is possible to prevent or slow its progression. It begins by acknowledging potential conflicts of interest from clinical trials and industry relationships. It then explains that relapsing and progressive MS are part of a continuum, with continuous tissue loss driving progression even during relapsing stages. While symptoms and deficits differ depending on tissue loss and brain reserve, MS remains a single disease. Later stages are determined more by neuroanatomy and length of affected nerve fibers. The document advocates considering progressive MS patients' expectations realistically and evaluating therapies based on proven efficacy in both relapsing and progressive MS as well as safety and convenience factors.
This document discusses transverse myelitis, including its causes, differential diagnosis compared to multiple sclerosis and neuromyelitis optica, diagnostic testing, medical management, and role of physical therapy. Transverse myelitis is an inflammation of the spinal cord that presents with weakness, sensory changes, and bowel/bladder issues. It is usually caused by viral infections but can also be idiopathic. Differential diagnosis considers multiple sclerosis, neuromyelitis optica, and other potential causes. Medical management focuses on steroids, plasma exchange, and other immunotherapies. Physical therapy aims to improve function and manage symptoms like spasticity.
Dr. Shubham Garg discusses neuromyelitis optica (NMO), an autoimmune condition where antibodies attack aquaporin-4 in the central nervous system. NMO predominantly affects women and has a median age of onset of 32-41 years. Key clinical features include transverse myelitis, typically longitudinally extensive, and severe optic neuritis. Treatment involves high-dose steroids for acute attacks and immunosuppressants like azathioprine to reduce relapse rates. Prognosis is generally worse than multiple sclerosis due to risk of cumulative disability, though relapse rates can be lowered with appropriate treatment.
The document discusses oligodendroglioma, a rare type of brain tumor. Key points include:
- Oligodendrogliomas most commonly occur in the cerebral hemispheres in adults aged 30-50. Surgery is the primary treatment when possible, along with radiation and chemotherapy.
- MRI is used for diagnosis. Tumors are graded on a scale of II-III according to the WHO system. Lower grade (II) tumors can later transform to higher grade (III).
- While surgery aims for gross total resection, this is often not possible. Adjuvant treatment depends on factors like tumor location and extent of resection. Radiation is usually given after symptoms appear rather than
Terrando et al-2015-anesthesia_&_analgesiasamirsharshar
This article summarizes discussions from a workshop on perioperative neurotoxicity in the elderly. The workshop included presentations on:
1) Preclinical evidence that surgery and anesthesia can cause neuroinflammation and cognitive impairment in rodent models, especially in vulnerable populations like the elderly.
2) Emerging human biomarkers like CSF tau levels that show potential to objectively measure postoperative neuronal injury and predict cognitive outcomes.
3) Preliminary clinical studies finding associations between postoperative cytokines, blood-brain barrier disruption, and delirium; however, interventions like glucocorticoids have not proven effective yet.
4) The need for standardized nomenclature and consideration of preexisting patient vulnerabilities in clinical studies to help resolve
Understanding Multiple Sclerosis and Management UpdatesAjay Kumar
Brief review on Multiple sclerosis and things we need to consider before choosing a DMT. Slides on management of acute flares with pregnancy recommendations.
Multiple sclerosis and newer concept in management till 2014 maydrnikhilver
This document provides information about Multiple Sclerosis (MS), including what it is, possible causes, types, diagnosis, treatment and newer concepts in management. It defines MS as a chronic neurological disorder affecting the central nervous system, where myelin is destroyed in the brain and spinal cord. The exact cause is unknown but is believed to involve immunological, viral, environmental and genetic factors. Diagnosis involves clinical symptoms and tests like MRI, CSF examination and evoked potentials. Treatment includes managing acute attacks, reducing disease activity through medications, and symptom management. Newer oral medications and concepts in disease-modifying therapies are discussed.
Debate risk stratification in hcm is feasible using a clinical score (pro)drucsamal
This document discusses risk stratification for sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). It presents data showing that SCD risk can be estimated using a clinical risk score that incorporates multiple factors such as age, family history of SCD, and results from tests like echocardiogram and Holter monitoring. Specifically, it finds patients with 2 or more risk factors have a 1.6% annual risk of SCD compared to 0.5% for 1 risk factor and 0.3% for no risk factors. The risk score provides a more accurate prediction of individual SCD risk than previous methods. However, risk stratification remains an imperfect science, and clinical judgment still has an important
This case presentation is for Noah Marzook, who presented with decreased vision in both eyes, more severe in the right eye, along with a central visual field defect in the right eye. MRI showed bilateral optic nerve swelling and white matter lesions. Given the clinical features of optic neuritis and MRI findings, the patient was diagnosed with multiple sclerosis (MS). MS is characterized by episodes of demyelination in the central nervous system. A history of optic neuritis significantly increases the risk of developing MS within 10-15 years. Early treatment of MS can delay progression to clinically definite MS but long-term effects on disability are unknown.
This presentation by Gavin Giovannoni looks at the new treatment paradigm for MS. It includes: arguments for early treatment in multiple sclerosis, the effect of MS on quality of life and whether highly-effective treatments stabilise MS.
It was presented at the MS Trust Annual Conference in November 2013.
Dr Trevor Pickersgill - Diagnosing a RelapseMS Trust
1) Diagnosing relapses in multiple sclerosis (MS) patients can be complex, as relapses can mimic other conditions and symptoms are not always clearly MS-related.
2) It is important to properly diagnose relapses to determine the MS disease course, guide treatment decisions, and understand the patient's prognosis.
3) In addition to traditional relapses, atypical presentations must be considered, such as relapses related to MS treatments, infections, neurological conditions mimicking MS, and non-neurological or functional issues. A thorough examination is needed.
1. Brain atrophy occurs across all stages of multiple sclerosis (MS), with around 40% of cortical neurons being lost over a lifetime without intervention. Early treatment with disease-modifying therapies (DMT) can help reduce disability and protect brain health.
2. Both inflammatory lesions and neurodegeneration are associated with disability progression in MS. Gadolinium-enhancing lesions are not fully indicative of disease phenotypes and inflammation may be present even without new lesions.
3. DMT have been shown to reduce disability accrual even at advanced stages of MS. While early treatment is important, evidence suggests that people with progressive forms may also benefit. Interventions should focus on outcomes beyond just lesion activity.
This document discusses the impact of meningitis on the brain and an overview of neurorehabilitation for children with neurological sequelae from meningitis. It provides details on the pathophysiology of meningitis and how it can cause brain damage. The document also presents clinical evidence from cases of meningitis, including outcomes and the incidence of post-meningitic hydrocephalus requiring shunt surgery. It concludes with an overview of neurorehabilitation services and a proposed model for a regional pediatric neurorehabilitation network.
This document discusses the formation and roles of support groups for transmissible spongiform encephalopathies (TSEs) like Creutzfeldt-Jakob disease (CJD) over time. It outlines the timeline of when major support groups around the world were established from 1992 to present. It also discusses the challenges faced in understanding and finding treatments for these fatal neurodegenerative diseases.
This document provides an overview of multiple sclerosis (MS) models and the challenges of translating findings from animal models to clinical applications. It discusses key aspects of MS like pathogenesis, clinical courses, and neurodegeneration. Common MS models like experimental autoimmune encephalomyelitis (EAE) are described along with their limitations in mimicking the human disease. Issues like preclinical failure to translate findings and limitations of experimental design that can contribute to clinical trial failures are reviewed. Guidelines for improving experimental design and reporting are also mentioned.
This document discusses recent developments in the treatment of multiple sclerosis (MS). It notes that early treatment with immunomodulatory therapies can slow disease progression and reduce future disability. Patients presenting with a clinically isolated syndrome or radiologically isolated syndrome, who have abnormal MRI findings but no or limited symptoms, are now treated early to prevent or delay their first clinical relapse of MS. The document reviews the inflammatory and demyelinating nature of MS and how the newly discovered glymphatic system may help immune cells enter the central nervous system to cause MS lesions.
Neurological Aspects of Tuberous Sclerosis Ade Wijaya
Tuberous sclerosis is an autosomal dominant genetic disorder that affects multiple organ systems. More than 90% of individuals experience neurological effects including epilepsy and neuropsychiatric symptoms. Brain imaging reveals tubers, subependymal nodules, and other abnormalities. Treatment involves early and aggressive treatment of epilepsy as well as mTOR inhibitors which target the molecular basis of the condition.
This document summarizes primary nervous system tumors in adults. It discusses that primary brain tumors arise from different central nervous system cells and account for about 2% of cancers. Meningiomas are the most common non-malignant tumors, while gliomas account for 75% of malignant brain tumors, over half being glioblastomas. Symptoms, diagnostic imaging techniques, treatment options including surgery, radiation therapy, chemotherapy are described. The management of primary brain tumors in adults and children of different age groups is summarized.
This document discusses progressive multiple sclerosis (MS) and whether it is possible to prevent or slow its progression. It begins by acknowledging potential conflicts of interest from clinical trials and industry relationships. It then explains that relapsing and progressive MS are part of a continuum, with continuous tissue loss driving progression even during relapsing stages. While symptoms and deficits differ depending on tissue loss and brain reserve, MS remains a single disease. Later stages are determined more by neuroanatomy and length of affected nerve fibers. The document advocates considering progressive MS patients' expectations realistically and evaluating therapies based on proven efficacy in both relapsing and progressive MS as well as safety and convenience factors.
This document discusses transverse myelitis, including its causes, differential diagnosis compared to multiple sclerosis and neuromyelitis optica, diagnostic testing, medical management, and role of physical therapy. Transverse myelitis is an inflammation of the spinal cord that presents with weakness, sensory changes, and bowel/bladder issues. It is usually caused by viral infections but can also be idiopathic. Differential diagnosis considers multiple sclerosis, neuromyelitis optica, and other potential causes. Medical management focuses on steroids, plasma exchange, and other immunotherapies. Physical therapy aims to improve function and manage symptoms like spasticity.
Dr. Shubham Garg discusses neuromyelitis optica (NMO), an autoimmune condition where antibodies attack aquaporin-4 in the central nervous system. NMO predominantly affects women and has a median age of onset of 32-41 years. Key clinical features include transverse myelitis, typically longitudinally extensive, and severe optic neuritis. Treatment involves high-dose steroids for acute attacks and immunosuppressants like azathioprine to reduce relapse rates. Prognosis is generally worse than multiple sclerosis due to risk of cumulative disability, though relapse rates can be lowered with appropriate treatment.
The document discusses oligodendroglioma, a rare type of brain tumor. Key points include:
- Oligodendrogliomas most commonly occur in the cerebral hemispheres in adults aged 30-50. Surgery is the primary treatment when possible, along with radiation and chemotherapy.
- MRI is used for diagnosis. Tumors are graded on a scale of II-III according to the WHO system. Lower grade (II) tumors can later transform to higher grade (III).
- While surgery aims for gross total resection, this is often not possible. Adjuvant treatment depends on factors like tumor location and extent of resection. Radiation is usually given after symptoms appear rather than
Terrando et al-2015-anesthesia_&_analgesiasamirsharshar
This article summarizes discussions from a workshop on perioperative neurotoxicity in the elderly. The workshop included presentations on:
1) Preclinical evidence that surgery and anesthesia can cause neuroinflammation and cognitive impairment in rodent models, especially in vulnerable populations like the elderly.
2) Emerging human biomarkers like CSF tau levels that show potential to objectively measure postoperative neuronal injury and predict cognitive outcomes.
3) Preliminary clinical studies finding associations between postoperative cytokines, blood-brain barrier disruption, and delirium; however, interventions like glucocorticoids have not proven effective yet.
4) The need for standardized nomenclature and consideration of preexisting patient vulnerabilities in clinical studies to help resolve
Understanding Multiple Sclerosis and Management UpdatesAjay Kumar
Brief review on Multiple sclerosis and things we need to consider before choosing a DMT. Slides on management of acute flares with pregnancy recommendations.
Multiple sclerosis and newer concept in management till 2014 maydrnikhilver
This document provides information about Multiple Sclerosis (MS), including what it is, possible causes, types, diagnosis, treatment and newer concepts in management. It defines MS as a chronic neurological disorder affecting the central nervous system, where myelin is destroyed in the brain and spinal cord. The exact cause is unknown but is believed to involve immunological, viral, environmental and genetic factors. Diagnosis involves clinical symptoms and tests like MRI, CSF examination and evoked potentials. Treatment includes managing acute attacks, reducing disease activity through medications, and symptom management. Newer oral medications and concepts in disease-modifying therapies are discussed.
Debate risk stratification in hcm is feasible using a clinical score (pro)drucsamal
This document discusses risk stratification for sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). It presents data showing that SCD risk can be estimated using a clinical risk score that incorporates multiple factors such as age, family history of SCD, and results from tests like echocardiogram and Holter monitoring. Specifically, it finds patients with 2 or more risk factors have a 1.6% annual risk of SCD compared to 0.5% for 1 risk factor and 0.3% for no risk factors. The risk score provides a more accurate prediction of individual SCD risk than previous methods. However, risk stratification remains an imperfect science, and clinical judgment still has an important
This case presentation is for Noah Marzook, who presented with decreased vision in both eyes, more severe in the right eye, along with a central visual field defect in the right eye. MRI showed bilateral optic nerve swelling and white matter lesions. Given the clinical features of optic neuritis and MRI findings, the patient was diagnosed with multiple sclerosis (MS). MS is characterized by episodes of demyelination in the central nervous system. A history of optic neuritis significantly increases the risk of developing MS within 10-15 years. Early treatment of MS can delay progression to clinically definite MS but long-term effects on disability are unknown.
This presentation by Gavin Giovannoni looks at the new treatment paradigm for MS. It includes: arguments for early treatment in multiple sclerosis, the effect of MS on quality of life and whether highly-effective treatments stabilise MS.
It was presented at the MS Trust Annual Conference in November 2013.
Dr Trevor Pickersgill - Diagnosing a RelapseMS Trust
1) Diagnosing relapses in multiple sclerosis (MS) patients can be complex, as relapses can mimic other conditions and symptoms are not always clearly MS-related.
2) It is important to properly diagnose relapses to determine the MS disease course, guide treatment decisions, and understand the patient's prognosis.
3) In addition to traditional relapses, atypical presentations must be considered, such as relapses related to MS treatments, infections, neurological conditions mimicking MS, and non-neurological or functional issues. A thorough examination is needed.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Before it is too late
1. Before it’s too late: why time
matters in MS
João José Cerqueira
School of Medicine, University of Minho, Braga
2. Disclosures
I have received research funding from Biogen and
consultancy/speaker fees from Bayer, Biogen, Merck,
Novartis, Roche, Sanofi-Genzyme, Teva.
3. It is never too late to try
to STOP multiple
sclerosis
5. “MS is like hot iron, you have to
beat it while it is still hot!”
Cetautomatix in “The big fight!”
6. MS damages the entire brain
Kutzelnigg et al (2005) Brain
Popescu et al (2013) Continuum (Minneap Minn)
NeoC9 (complement) H+E (astrocytes) Bielschowsky (axons)
TypeIIlesion
Nikic et al (2011) Nature Med
17. Most certainly...
Given the significant mean differences, the model included the
following variables: disease duration, disease course, 9HPT,
SDMT, Logical Memory, and WCST.
As shown in Table 2, the only predictor of employment status
was the SDMT, accounting for 15–20% of the variance with an
overall accuracy of 67%.
Mult Scler. 2014; 20:112-5.
Design tips - narrative
Always consider your audience, who are they, what do they expect, how much will they know, what are the key messages they need to take away?
Tell a story - have a beginning a middle and an end.
Slides should follow a natural progression.
Remember the three times rule - tell your audience what you are going to tell them, tell it, and then summarise it.
Design tips – colour and images
Avoid using all the available colours. Blue is always our core colour, try not to use more than 2 secondary colours from the palette and only one secondary colour can be used on any given slide.
Use images carefully. They should help the audience relate slide information to real world situations. Always ensure good legibility is maintained when text is placed over images.
Do not use clipart.
Use graphics after careful consideration. Only use them if it adds to the communication.
Additional logos – for partners or other parties you co-present with – please place the logo in the bottom right hand corner